Search

Search Constraints

You searched for: Author/Creator Spriggs, David R.

Search Results

1. A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer. Issue 6 (1st June 2018)

2. A Randomized Trial of Prophylactic Extended Carboplatin Infusion to Reduce Hypersensitivity Reactions in Recurrent Ovarian Cancer. Issue 6 (July 2018)

3. Beyond the dose‐limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program. Issue 8 (24th February 2016)

4. BRAF Mutation is associated with early stage disease and improved outcome in patients with low‐grade serous ovarian cancer 1. Issue 3 (28th August 2012)

5. Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference. Issue 12 (5th March 2019)

6. Effect of Mismatch Repair Status on Outcome of Early-Stage Grade 1 to 2 Endometrial Cancer Treated With Vaginal Brachytherapy. (25th November 2021)

7. Effect of Mismatch Repair Status on Outcome of Early-Stage Grade 1 to 2 Endometrial Cancer Treated With Vaginal Brachytherapy. (January 2022)

8. Identifying Clinical Improvement in Consolidation Single-Arm Phase 2 Trials in Patients With Ovarian Cancer in Second or Greater Clinical Remission. Issue 1 (1st January 2012)

9. Intravenous aflibercept in patients with platinum‐resistant, advanced ovarian cancer: Results of a randomized, double‐blind, phase 2, parallel‐arm study. Issue 3 (11th October 2013)

10. Intravenous aflibercept in patients with platinum‐resistant, advanced ovarian cancer: Results of a randomized, double‐blind, phase 2, parallel‐arm study. Issue 3 (11th October 2013)